Steven Cohen’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
Steven Cohen's CRDL Position: Q3 2026 in Review
Steven Cohen increased its Cardiol Therapeutics (CRDL) stake by 9,385% in Q3 2026, buying an estimated $2.74M and bringing the position to 1,740,891 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2193.
Steven Cohen first reported a position in CRDL in Q2 2026 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- Steven Cohen held 1,740,891 shares of Cardiol Therapeutics worth $2.89M as of Q3 2026.
- Steven Cohen bought 1,722,537 Cardiol Therapeutics shares in Q3 2026, an estimated $2.74M.
- Cardiol Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2193 holding.
- Steven Cohen first reported a position in Cardiol Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.